These pages are intended for Health Care Professionals
If you are prescribing an anti-VEGF treatment such as Beovu® (brolucizumab), Lucentis® (ranibizumab), Eylea® (aflibercept) or a treatment indicated for wet age-related macular degeneration, the ICD 10 CM diagnosis codes for the condition are below:
| Diagnosis codes | Macular degeneration |
|---|---|
| H35.32 | Exudative age-related macular degeneration |
| H35.321 | Exudative age-related macular degeneration, right eye |
| H35.3210.. | stage unspecified |
| H35.3211 .. | with active choroidal neovascularization |
| H35.3212 .. | with inactive choroidal neovascularization |
| H35.3213 .. | with inactive scar |
| H35.322 | Exudative age-related macular degeneration, left eye |
| H35.3223 .. | stage unspecified |
| H35.3131 .. | with active choroidal neovascularization |
| H35.3212 .. | with inactive choroidal neovascularization |
| H35.3213 .. | with inactive scar |
| H35.322 | early dry stage |
| H35.3132 .. | intermediate dry stage |
| H35.3133 .. | advanced atrophic without subfoveal involvement |
| H35.3134 .. | advanced atrophic with subfoveal involvement |
| H35.319 | Nonexudative age-related macular degeneration, unspecified eye |
| H35.3190 .. | stage unspecified |
| H35.3191 .. | early dry stage |
| H35.3192 .. | intermediate dry stage |
| H35.3193 .. | advanced atrophic without subfoveal involvement |
| H35.3194 .. | advanced atrophic with subfoveal involvement |
Learn more about Beovu®
Beovu® information pages
(Registration as a healthcare professional required)
Rate this content:
11/20 GLOPH/BRO/0307
